Page last updated: 2024-10-22

alendronate and Diabetes Insipidus

alendronate has been researched along with Diabetes Insipidus in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research Excerpts

ExcerptRelevanceReference
"The aim of this open prospective randomized study was to evaluate the effect of a 6-month treatment with alendronate on the bone mineral density (BMD) at lumbar spine in patients with central diabetes insipidus."9.09Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus. ( Colao, A; Di Somma, C; Faggiano, A; Filippella, M; Klain, M; Lombardi, G; Pivonello, R; Salvatore, M, 1999)
"The aim of this open prospective randomized study was to evaluate the effect of a 6-month treatment with alendronate on the bone mineral density (BMD) at lumbar spine in patients with central diabetes insipidus."5.09Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus. ( Colao, A; Di Somma, C; Faggiano, A; Filippella, M; Klain, M; Lombardi, G; Pivonello, R; Salvatore, M, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pivonello, R1
Faggiano, A1
Di Somma, C1
Klain, M1
Filippella, M1
Salvatore, M1
Lombardi, G1
Colao, A1

Trials

1 trial available for alendronate and Diabetes Insipidus

ArticleYear
Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:7

    Topics: Adolescent; Adult; Alendronate; Bone and Bones; Bone Density; Bone Diseases; Collagen; Collagen Type

1999